发明名称 DILTIAZEM CONTROLLED RELEASE FORMULATION
摘要 A once-a-day controlled release diltiazem formulation is described which includes: (a) from 20 to 50% by weight of enteric polymeric membrane coated pellets comprising a polymer membrane coated core which comprises a biologically inert core which is coated with a first layer which consists essentially of diltiazem and a polymeric binder; and a second layer which comprises a membrane comprising a pH dependent polymeric material; and (b) from 50% to 80% by weight of delayed pulse polymeric membrane coated pellets comprising a polymeric membrane coated core which comprises a biologically inert core which is coated with a first layer which consists essentially of diltiazem and a polymeric binder and a second layer which comprises a polymeric membrane which will substantially maintain its integrity in the varying pH conditions of the gastrointestinal tract but is permeable to diltiazem; and (c) a unit dose containment system.
申请公布号 CA2215378(C) 申请公布日期 2008.09.16
申请号 CA19962215378 申请日期 1996.03.13
申请人 ANDRX PHARMACEUTICALS, INC. 发明人 CHEN, CHIH-MING
分类号 A61K9/52;A61K31/55;A61K9/22;A61K9/30;A61K9/50;A61K9/58;A61K31/554;A61K47/30 主分类号 A61K9/52
代理机构 代理人
主权项
地址